Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

OLIGOMERIC HIV-1 ENVELOPE GLYCOPROTEINS

  • Read more about OLIGOMERIC HIV-1 ENVELOPE GLYCOPROTEINS
US Patent 6,039,957
Filed on 1997-03-03

CELLS EXPRESSING BOTH HUMAN CD4 AND A HUMAN FUSION ACCESSORY FACTOR ASSOCIATED WITH HIV INFECTION

  • Read more about CELLS EXPRESSING BOTH HUMAN CD4 AND A HUMAN FUSION ACCESSORY FACTOR ASSOCIATED WITH HIV INFECTION
US Patent 6,197,578
Filed on 1997-01-30

RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES

  • Read more about RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES
US Patent 6,054,567
Filed on 1997-04-11

NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS

  • Read more about NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS
Patent Cooperation Treaty
PCT/US1996/014937
Filed on 1996-09-18

Method Of Sampling, Amplifying And Quantifying Segment Of Nucleic Acid, Polymerase Chain Reaction Assembly Having Nanoliter-Sized Sample Chambers, and Method of Filing Assembly

  • Read more about Method Of Sampling, Amplifying And Quantifying Segment Of Nucleic Acid, Polymerase Chain Reaction Assembly Having Nanoliter-Sized Sample Chambers, and Method of Filing Assembly
US Patent 6,143,496
Filed on 1997-04-17

HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES

  • Read more about HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES
US Application 08/469,882
Filed on 1995-06-05

HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES

  • Read more about HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES
US Application 08/467,236
Filed on 1995-06-05

HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES

  • Read more about HYBRID PICORNAVIRUSES EXPRESSING CHLAMYDIAL EPITOPES
US Application 08/467,235
Filed on 1995-06-05

Antibodies and Other Ligands Directed Against KIR2DL4 Receptor For Production of Interferon Gamma

  • Read more about Antibodies and Other Ligands Directed Against KIR2DL4 Receptor For Production of Interferon Gamma
US Patent 7,435,801
Filed on 2003-04-18

Self-replicating Infectious RSV Particles Comprising Recombinant RSV Genomes or Antigenomes And The N,P,L, And M2 Protein

  • Read more about Self-replicating Infectious RSV Particles Comprising Recombinant RSV Genomes or Antigenomes And The N,P,L, And M2 Protein
US Patent 6,264,957
Filed on 1996-09-27

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 558
  • Page 559
  • Page 560
  • Page 561
  • Page 562
  • Page 563
  • Page 564
  • Page 565
  • Page 566
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health